Prognostic benefit of preoperative transarterial chemoembolization in upfront resectable large hepatocellular carcinoma: a multicentric propensity score based analysis of European high-volume centers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic benefit of preoperative transarterial chemoembolization in upfront resectable large hepatocellular carcinoma: a multicentric propensity score based analysis of European high-volume centers

Published:2024-06 Issue:6 Volume:26 Page:840-850
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Giannone Fabio,Felli Emanuele^ORCID,Cipriani Federica^ORCID,Branciforte Bruno,Rhaiem Rami^ORCID,Al Taweel Bader^ORCID,Brustia Raffaele,Salame Ephrem,Panaro Fabrizio,Sommacale Daniele,Piardi Tullio,Torzilli Guido^ORCID,Aldrighetti Luca,Schuster Catherine^ORCID,Pessaux Patrick

Publisher

Elsevier BV

Reference40 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Hepatocellular carcinoma;Vogel;Lancet Lond Engl,2022

3. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update;Reig;J Hepatol,2022

4. The prognosis of single large hepatocellular carcinoma was distinct from Barcelona Clinic Liver Cancer Stage A or B: the role of albumin-bilirubin grade;Fang;Liver Cancer,2018

5. Solitary large hepatocellular carcinoma: staging and treatment strategy;Liu;PLoS One,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial;Trials;2024-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP